Skip to main content
Ambu logo

Ambu — Investor Relations & Filings

Ticker · AMBU ISIN · DK0060946788 LEI · 5299008W2A69WX355710 CO Manufacturing
Filings indexed 1,332 across all filing types
Latest filing 2012-03-30 Share Issue/Capital Cha…
Country DK Denmark
Listing CO AMBU

Ambu is a global medical technology company that develops, manufactures, and markets single-use medical devices. A pioneer and market leader in single-use endoscopy, the company provides a broad portfolio of solutions for healthcare professionals across various clinical areas, including endoscopy, anesthesia, and patient monitoring. Its key products include the aScope™ line of single-use flexible endoscopes for pulmonology, gastroenterology, and urology, as well as video laryngoscopes. Ambu's solutions are designed to improve patient safety by eliminating the risk of cross-contamination associated with reusable devices, while also enhancing workflow efficiency in clinical environments by ensuring sterile, high-quality equipment is always available.

Recent filings

Filing Released Lang Actions
Share Issue/Capital Change 2012
Share Issue/Capital Change Classification · 95% confidence The document text discusses the exercise of previously granted stock subscription rights (warrants) by management employees, resulting in a capital increase through the issuance of new B-shares. This directly relates to changes in the company's capital structure and the issuance of new shares based on existing rights. This aligns best with the 'Share Issue/Capital Change' definition (SHA), which covers new share issues and capital structure changes, rather than just a general financing update (CAP) or a transaction in own shares (POS, which usually implies buybacks/treasury stock). The context is a specific execution of a capital plan.
2012-03-30 Danish
Share Issue/Capital Change 2012
Share Issue/Capital Change Classification · 99% confidence The document discusses the exercise (udnyttelse) of stock subscription rights (aktietegningsretter or warrants) granted under a previous authorization from the Annual General Meeting. It details the number of shares being issued, the subscription price (udnyttelseskurs), and the timeline for capital increase. This action directly relates to changes in the company's capital structure and financing activities, specifically through employee incentive programs involving equity. This aligns best with the 'Capital/Financing Update' category (CAP), as it announces the execution of a capital increase via warrant exercise, rather than a general announcement of a report (RPA) or a general regulatory filing (RNS).
2012-03-30 English
M&A Activity 2012
M&A Activity Classification · 99% confidence The document text is very short (374 characters) and describes a specific corporate action: Ambu has entered into an agreement to acquire the electrode business of Unomedical. This is a significant corporate transaction involving a potential merger or acquisition. Based on the definitions, the most appropriate category for an announcement related to a merger proposal or takeover bid is 'M&A Activity' (TAR). It is not a general regulatory filing (RNS) because it describes a specific, material event.
2012-03-01 Danish
M&A Activity 2012
M&A Activity Classification · 99% confidence The document details a specific corporate action: Ambu entering an agreement to acquire Unomedical's electrode business. It outlines the terms, assets being purchased, financial implications (purchase sum, revenue impact), and conditions for closing (regulatory clearance). This type of announcement, concerning a significant transaction like an acquisition or merger proposal, directly aligns with the definition of M&A Activity (TAR). It is not a general earnings release (ER), a full annual report (10-K), or a management discussion (MDA), but a specific transaction announcement.
2012-03-01 English
Regulatory Filings 2012
Regulatory Filings Classification · 99% confidence The document text is very short (1018 characters) and discusses a strategic operational change: simplifying the supply chain by consolidating production in Asia and moving finished goods inventory from Denmark to Germany, involving a logistics partner (FIEGE). It mentions the expected completion date (Summer 2012) and confirms the financial impact is already included in previous guidance for FY 2011/12. This content is not a formal financial report (like 10-K or IR), nor is it a standard announcement like a dividend, earnings release, or management change. It describes a significant business restructuring/operational update that impacts future competitiveness and logistics. Given the options, this best fits under a general business update or strategic announcement. Since there isn't a specific 'Business Strategy Update' code, and it's not a formal regulatory filing like a DIRS or MRQ, it falls closest to a general announcement. However, if this is related to a major operational shift that might affect financing or capital structure indirectly, 'CAP' (Capital/Financing Update) might be considered, but the text focuses purely on logistics and supply chain. Given the lack of specific regulatory headers or financial statement excerpts, and its nature as a strategic operational announcement, it is most likely a general regulatory announcement or a specific type of corporate action announcement. Since it details a significant operational change that impacts future cost structure and competitiveness, and it is not a standard report, 'RNS' (Regulatory Filings - fallback) is the safest general classification, although 'LTR' (Legal Proceedings Report) or 'MDA' (Management Reports) are less fitting. Considering the context of corporate filings, this reads like a press release detailing a strategic move. If we must choose from the provided list, and it's not a formal report, 'RNS' is the appropriate fallback for non-standard corporate news releases.
2012-01-17 Danish
Regulatory Filings 2012
Regulatory Filings Classification · 95% confidence The document text is a short announcement detailing a strategic operational change: the consolidation of European distribution inventory into a central location in Germany, involving a contract with a logistics company (FIEGE). It mentions the financial impact has been recognized in the previously announced outlook for FY 2011/12. This is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). It describes a significant business restructuring/operational update that impacts capital structure or financing indirectly, but most closely aligns with a general business update or strategic announcement. Since it doesn't fit the specific categories like M&A (TAR), Capital Change (CAP), or Director Dealing (DIRS), and it is a direct announcement of a business event rather than a report publication announcement (RPA), it falls best under the general 'Regulatory Filings' (RNS) category as a miscellaneous, non-standard announcement, or potentially a very specific type of operational update not explicitly listed. Given the options, RNS is the most appropriate fallback for a press release detailing operational strategy changes.
2012-01-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.